Madrigal Pharmaceuticals, Inc. (MDGL)
447.00
-2.74
(-0.61%)
USD |
NASDAQ |
Oct 19, 16:00
447.00
0.00 (0.00%)
After-Hours: 16:14
Madrigal Pharmaceuticals Cash from Operations (Annual) : -189.55M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -189.55M |
| December 31, 2024 | -455.57M |
| December 31, 2023 | -324.23M |
| December 31, 2022 | -224.86M |
| December 31, 2021 | -183.92M |
| December 31, 2020 | -157.56M |
| December 31, 2019 | -41.62M |
| December 31, 2018 | -25.51M |
| December 31, 2017 | -22.32M |
| December 31, 2016 | -17.61M |
| December 31, 2015 | -3.142M |
| December 31, 2014 | -78.92M |
| Date | Value |
|---|---|
| December 31, 2013 | -77.41M |
| December 31, 2012 | -54.14M |
| December 31, 2011 | -47.30M |
| December 31, 2010 | -38.20M |
| December 31, 2009 | -26.81M |
| December 31, 2008 | -37.94M |
| December 31, 2007 | 27.22M |
| December 31, 2006 | -52.98M |
| December 31, 2005 | -61.88M |
| December 31, 2004 | -33.80M |
| December 31, 2003 | -23.61M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Insmed, Inc. | -935.01M |
| United Therapeutics Corp. | 1.561B |
| Karyopharm Therapeutics, Inc. | -75.37M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |